Celgene Avilomics Research

Homology Medicines Inc. is a clinical-stage biotechnology company based in Bedford, MA, dedicated to developing genetic medicines aimed at delivering durable treatments for individuals affected by rare genetic conditions. By leveraging their proprietary AAVHSC vector platform, the company focuses on precision in gene therapy and gene editing, ensuring a solid scientific foundation for its therapeutic programs. With a commitment to patient-centric progress, Homology Medicines emphasizes collaboration, integrity, and open communication throughout the development process. Their innovative approach combines deep scientific insight with flexible, forward-thinking manufacturing, allowing them to efficiently conduct clinical trials and remain responsive to the needs of patients and healthcare stakeholders. Generated from the website

Toxikon, based in Bedford, MA, specializes in providing comprehensive preclinical research services to pharmaceutical, biotechnology, and medical device companies. The company offers a range of testing services to support the development of new drugs and medical products, ensuring compliance with regulatory requirements. Generated from their business information